APEX1 and brain neoplasm: An inhibitor of the DNA repair activity of APE1/Ref-1 has been difficult to identify and develop preclinically, therefore two recent studies in pediatric and adult brain tumors utilized nanoparticle delivery of APE1/Ref-1 siRNA to achieve sensitivity to RT (168, 169).